Get started
Author

Hermine Agis

Observed names: Agis Hermine, Agis, Hermine, H A Agis, H AGIS, H Agis, H. AGIS, H. Agis, HERMINE AGIS, Hermine AGIS, Hermine Agis,
Observed institutions: Semmelweis University, University of Vienna, Universidad de Alcalá, Vienna General Hospital, Comprehensive Cancer Center Vienna, St Anna Children's Hospital, Medical University of Vienna
ORCID: 0000-0002-1125-0211
Observed ORCID: 0000-0002-1125-0211
OpenAlex ID: A5007286146
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
2006 · Brian J. Druker, François Guilhot, et al. · New England Journal of Medicine · 3,493
PDF
Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture
1992 · P Valent, E Spanblochl, et al. · Blood · 440
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
2018 · Meletios A Dimopoulos, Francesca Gay, et al. · The Lancet · 237
PDF
Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells
1995 · W Füreder, H Agis, et al. · The Journal of Immunology · 193
Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis
2017 · Philipp Wohlfarth, Hermine Agis, et al. · Journal of Intensive Care Medicine · 139
Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes
1996 · H. AGIS, W. FÜREDER, et al. · Immunology · 138
PDF
The human cardiac mast cell: localization, isolation, phenotype, and functional characterization
1994 · WR Sperr, HC Bankl, et al. · Blood · 138
PDF
Light-Chain and Transthyretin Cardiac Amyloidosis in Severe Aortic Stenosis: Prevalence, Screening Possibilities, and Outcome
2020 · Christian Nitsche, Stefan Aschauer, et al. · European Journal of Heart Failure · 135
PDF
Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c- kit +, CD34+, Ly-, CD14-, CD17-, colony-forming cell.
1993 · H Agis, M Willheim, et al. · The Journal of Immunology · 133
CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection
2020 · Konstantin Doberer, Johannes Kläger, et al. · Transplantation · 122
A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis
2002 · H. Agis, A. Weltermann, et al. · Annals of Hematology · 118
Variable expression of activation‐linked surface antigens on human mast cells in health and disease
2001 · P. Valent, G.‐H. Schernthaner, et al. · Immunological Reviews · 109
The Mast Cell as Site of Tissue-Type Plasminogen Activator Expression and Fibrinolysis
1999 · Christian Sillaber, Mehrdad Baghestanian, et al. · The Journal of Immunology · 100
PDF
Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology
2009 · W. R. Sperr, A. El‐Samahi, et al. · European Journal of Clinical Investigation · 99
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF
2010 · A D'Addio, A Curti, et al. · Bone Marrow Transplantation · 89
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial
2020 · Marc S Raab, Monika Engelhardt, et al. · The Lancet Haematology · 82
Indolent Systemic Mastocytosis with Elevated Serum Tryptase, Absence of Skin Lesions, and Recurrent Severe Anaphylactoid Episodes
2005 · Stefan Florian, Maria-Theresa Krauth, et al. · International Archives of Allergy and Immunology · 79
Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement
2020 · Diana Bonderman, Gerhard Pölzl, et al. · Wiener klinische Wochenschrift · 70
PDF
Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412
2006 · Karl J. Aichberger, Matthias Mayerhofer, et al. · Blood · 70
PDF
Molecular and Functional Characterization of the Urokinase Receptor on Human Mast Cells
1997 · C. Sillaber, M. Baghestanian, et al. · Journal of Biological Chemistry · 69
PDF
Differential expression of cell surface integrins on human mast cells and human basophils
1992 · W. R. Sperr, H. Agis, et al. · Annals of Hematology · 64
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018
2023 · Giovanni Palladini, Stefan Schönland, et al. · Blood Cancer Journal · 57
PDF
Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasms
2001 · Puchit Samorapoompichit, Hans P. Kiener, et al. · Blood · 56
The surface membrane antigen phenotype of human blood basophils
1994 · W. Füreder, H. Agis, et al. · Allergy · 55
Detection of differentiation‐ and activation‐linked cell surface antigens on cultured mast cell progenitors
2005 · G.‐H. Schernthaner, A. W. Hauswirth, et al. · Allergy · 53
Works count: 215
Citation count: 8,498
H-index: 40
I10-index: 96
Year
Topic
Type